SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000947871-24-000158
Filing Date
2024-02-14
Accepted
2024-02-14 19:21:29
Documents
2
Group Members
ORBIMED CAPITAL LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G ss3005752_sc13g.htm SC 13G 53151
2 JOINT FILING AGREEMENT ss3005752_ex99a.htm EX-99.A 6637
  Complete submission text file 0000947871-24-000158.txt   61414
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13G

Mailing Address 301 BINNEY STREET 3RD FLOOR CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET 3RD FLOOR CAMBRIDGE MA 02142 857-259-3860
Scholar Rock Holding Corp (Subject) CIK: 0001727196 (see all company filings)

IRS No.: 823750435 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90496 | Film No.: 24641462
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)